NeoGenomics Inc (NEO) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $10.17
• Market Cap: $1.27B
• EPS: $-0.85
• 52-Week High: $13.74
• 52-Week Low: $4.72

Market Sentiment

NeoGenomics Inc currently has a Bullish sentiment score of 0.18.

About NeoGenomics Inc

NeoGenomics, Inc. is a leading provider of cancer-focused diagnostics and testing services, with an extensive laboratory network across the United States, Europe, and Asia. Headquartered in Fort Myers, Florida, the company excels in advanced molecular and genomic testing solutions, empowering personalized treatment strategies that significantly improve patient outcomes. With a commitment to innovation and quality, NeoGenomics leverages cutting-edge technology and a wide range of diagnostic te...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for NeoGenomics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NEO pay dividends?

NeoGenomics Inc (NEO) does not currently pay a regular dividend.

What is NEO's market cap?

NeoGenomics Inc (NEO) has a market capitalization of $1.27B with a current stock price of $10.17.